ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,941
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Author(s):
Publication date:
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
3,941
Final results of a multicenter, open-labeled phase II trial of dovitinib (TKI1258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3
Authors:
MI Milowsky
,
C Dittrich
,
ID Martinez
…
Phase 2 trial of dovitinib in bacillus Calmette‐Guerin (BCG) refractory urothelial carcinoma (UC) with tumor FGFR3 mutations or over‐expression: Hoosier Cancer Research Network GU12‐157
Authors:
NM Hahn
,
TJ Bivalacqua
,
A. ROSS
A phase Ib study of the FGFR/VEGFR inhibitor dovitinib with gemcitabine and capecitabine in advanced solid tumor and pancreatic cancer patients
Authors:
WW Ma
,
H XIE
,
G Fetterly
See all similar
Cited by
1
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
Authors:
Edward Carter
,
Abigail Coetzee
,
Elena Tomas Bort
…
See all cited by